Search

everythinglearnresearchcommunity

for

Search:↓

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

Removing the Crif1 gene in mouse skin disrupts skin balance and hair growth.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

Blocking CXCR4 may help treat hidradenitis suppurativa.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Raltegravir may cause hair loss in some patients.